Inflammatory receptors and pathways in human NT2-N neurons during hypoxia and reoxygenation. Impact of acidosis

Brain Research

Volumn 1217, Issue , 2008, Pages 37-49

  Frøyland, Elisabeth ^a   Skjæret, Camilla ^b   Wright, Marianne S ^a   Dalen, Marit Lunde ^a   Cvancarova, Milada ^c   Kasi, Cecilie ^a   Rootwelt, Terje ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acidosis; Cytokine receptor; Hypoxia; Inflammation; NT2 N neuron

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR4; CYTOKINE RECEPTOR; FAS ANTIGEN; HEAT SHOCK PROTEIN 70; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10 RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; RNA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ACIDOSIS; ARTICLE; BRAIN DAMAGE; BRAIN HYPOXIA; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; INFLAMMATION; NERVE CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REOXYGENATION;

ACIDOSIS; CELL HYPOXIA; CELLS, CULTURED; GENE EXPRESSION; HUMANS; INFLAMMATION; NEURONS; RECEPTORS, CYTOKINE; REPERFUSION INJURY;

EID: 45449084397     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.04.038     Document Type: Article

References (77)

1. Ali C., Nicole O., Docagne F., Lesne S., MacKenzie E.T., Nouvelot A., Buisson A., and Vivien D. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. J. Cereb. Blood Flow Metab. 20 (2000) 956-966
2. Allan S.M., and Rothwell N.J. Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2 (2001) 734-744
3. Allan S.M., and Pinteaux E. The interleukin-1 system: an attractive and viable therapeutic target in neurodegenerative disease. Curr. Drug Targets. CNS. Neurol. Disord. 2 (2003) 293-302
4. Almaas R., Pytte M., Lindstad J.K., Wright M., Saugstad O.D., Pleasure D., and Rootwelt T. Acidosis has opposite effects on neuronal survival during hypoxia and reoxygenation. J. Neurochem. 84 (2003) 1018-1027
5. Almaas R., Saugstad O.D., Pleasure D., and Rootwelt T. Effect of barbiturates on hydroxyl radicals, lipid peroxidation, and hypoxic cell death in human NT2-N neurons. Anesthesiology 92 (2000) 764-774
6. Asadullah K., Sterry W., and Volk H.D. Interleukin-10 therapy-review of a new approach. Pharmacol. Rev. 55 (2003) 241-269
7. Bachis A., Colangelo A.M., Vicini S., Doe P.P., De Bernardi M.A., Brooker G., and Mocchetti I. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J. Neurosci. 21 (2001) 3104-3112
8. Bakhiet M., Mousa A., Seiger A., and Andersson J. Constitutive and inflammatory induction of alpha and beta chemokines in human first trimester forebrain astrocytes and neurons. Mol. Immunol. 38 (2002) 921-929
9. Barrett M.J., Alones V., Wang K.X., Phan L., and Swerdlow R.H. Mitochondria-derived oxidative stress induces a heat shock protein response. J. Neurosci. Res. 78 (2004) 420-429
10. Basu A., Lazovic J., Krady J.K., Mauger D.T., Rothstein R.P., Smith M.B., and Levison S.W. Interleukin-1 and the interleukin-1 type 1 receptor are essential for the progressive neurodegeneration that ensues subsequent to a mild hypoxic/ischemic injury. J. Cereb. Blood Flow Metab. 25 (2005) 17-29
11. Beere H.M., Wolf B.B., Cain K., Mosser D.D., Mahboubi A., Kuwana T., Tailor P., Morimoto R.I., Cohen G.M., and Green D.R. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat. Cell Biol. 2 (2000) 469-475
12. Bona E., Andersson A.L., Blomgren K., Gilland E., Puka-Sundvall M., Gustafson K., and Hagberg H. Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr. Res. 45 (1999) 500-509
13. Botchkina G.I., Meistrell III M.E., Botchkina I.L., and Tracey K.J. Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol. Med. 3 (1997) 765-781
14. Boutet A., Salim H., Leclerc P., and Tardieu M. Cellular expression of functional chemokine receptor CCR5 and CXCR4 in human embryonic neurons. Neurosci. Lett. 311 (2001) 105-108
15. Chapman H., Piggot C., Andrews P.W., and Wann K.T. Characterisation of large-conductance calcium-activated potassium channels (BK(Ca)) in human NT2-N cells. Brain Res. 1129 (2007) 15-25
16. Coughlan C.M., McManus C.M., Sharron M., Gao Z., Murphy D., Jaffer S., Choe W., Chen W., Hesselgesser J., Gaylord H., Kalyuzhny A., Lee V.M., Wolf B., Doms R.W., and Kolson D.L. Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience 97 (2000) 591-600
17. Cowell R.M., Xu H., Galasso J.M., and Silverstein F.S. Hypoxic-ischemic injury induces macrophage inflammatory protein-1alpha expression in immature rat brain. Stroke 33 (2002) 795-801
18. Dziewulska D., and Mossakowski M.J. Cellular expression of tumor necrosis factor a and its receptors in human ischemic stroke. Clin. Neuropathol. 22 (2003) 35-40
19. Eklind S., Mallard C., Leverin A.L., Gilland E., Blomgren K., Mattsby-Baltzer I., and Hagberg H. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur. J. Neurosci. 13 (2001) 1101-1106
20. Felderhoff-Mueser U., Taylor D.L., Greenwood K., Kozma M., Stibenz D., Joashi U.C., Edwards A.D., and Mehmet H. Fas/CD95/APO-1 can function as a death receptor for neuronal cells in vitro and in vivo and is upregulated following cerebral hypoxic-ischemic injury to the developing rat brain. Brain Pathol. 10 (2000) 17-29
21. Felderhoff-Mueser U., Sifringer M., Pesditschek S., Kuckuck H., Moysich A., Bittigau P., and Ikonomidou C. Pathways leading to apoptotic neurodegeneration following trauma to the developing rat brain. Neurobiol. Dis. 11 (2002) 231-245
22. Felderhoff-Mueser U., Buhrer C., Groneck P., Obladen M., Bartmann P., and Heep A. Soluble Fas (CD95/Apo-1), soluble Fas ligand, and activated caspase 3 in the cerebrospinal fluid of infants with posthemorrhagic and nonhemorrhagic hydrocephalus. Pediatr. Res. 54 (2003) 659-664
23. Felszeghy K., Banisadr G., Rostene W., Nyakas C., and Haour F. Dexamethasone downregulates chemokine receptor CXCR4 and exerts neuroprotection against hypoxia/ischemia-induced brain injury in neonatal rats. Neuroimmunomodulation 11 (2004) 404-413
24. Friedman W.J. Cytokines regulate expression of the type 1 interleukin-1 receptor in rat hippocampal neurons and glia. Exp. Neurol. 168 (2001) 23-31
25. Froyland E., Wibrand F., Almaas R., Dalen I., Lindstad J.K., and Rootwelt T. Acidosis during reoxygenation has an early detrimental effect on neuronal metabolic activity. Pediatr. Res. 57 (2005) 488-493
26. Froyland E., Didenko P.E., Kvissel A.K., Almaas R., Pharo A., Skalhegg B.S., Mollnes T.E., and Rootwelt T. Effect of acidosis on IL-8 and MCP-1 during hypoxia and reoxygenation in human NT2-N neurons. Brain Res. 1113 (2006) 64-73
27. Gadient R.A., and Otten U. Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res. 637 (1994) 10-14
28. Gadient R.A., and Otten U. Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci. Lett. 182 (1994) 243-246
29. Garau A., Bertini R., Mosca M., Bizzarri C., Anacardio R., Triulzi S., Allegretti M., Ghezzi P., and Villa P. Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat. Eur. Cytokine Netw. 17 (2006) 35-41
30. Gary D.S., Bruce-Keller A.J., Kindy M.S., and Mattson M.P. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J. Cereb. Blood Flow Metab. 18 (1998) 1283-1287
31. Gillardon F., Lenz C., Waschke K.F., Krajewski S., Reed J.C., Zimmermann M., and Kuschinsky W. Altered expression of Bcl-2, Bcl-X, Bax, and c-Fos colocalizes with DNA fragmentation and ischemic cell damage following middle cerebral artery occlusion in rats. Brain Res. Mol. Brain Res. 40 (1996) 254-260
32. Goldman S.A., Pulsinelli W.A., Clarke W.Y., Kraig R.P., and Plum F. The effects of extracellular acidosis on neurons and glia in vitro. J. Cereb. Blood Flow Metab. 9 (1989) 471-477
33. Grilli M., Barbieri I., Basudev H., Brusa R., Casati C., Lozza G., and Ongini E. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur. J. Neurosci. 12 (2000) 2265-2272
34. Hardy M., Younkin D., Tang C.M., Pleasure J., Shi Q.Y., Williams M., and Pleasure D. Expression of non-NMDA glutamate receptor channel genes by clonal human neurons. J. Neurochem. 63 (1994) 482-489
35. Hedtjarn M., Leverin A.L., Eriksson K., Blomgren K., Mallard C., and Hagberg H. Interleukin-18 involvement in hypoxic-ischemic brain injury. J. Neurosci. 22 (2002) 5910-5919
36. Hesselgesser J., Halks-Miller M., DelVecchio V., Peiper S.C., Hoxie J., Kolson D.L., Taub D., and Horuk R. CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Curr. Biol. 7 (1997) 112-121
37. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., Bodmer J.L., Schneider P., Seed B., and Tschopp J. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1 (2000) 489-495
38. Jiang B.H., Semenza G.L., Bauer C., and Marti H.H. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am. J. Physiol. 271 (1996) C1172-C1180
39. Kelly S., Bieneman A., Horsburgh K., Hughes D., Sofroniew M.V., McCulloch J., and Uney J.B. Targeting expression of hsp70i to discrete neuronal populations using the Lmo-1 promoter: assessment of the neuroprotective effects of hsp70i in vivo and in vitro. J. Cereb. Blood Flow Metab. 21 (2001) 972-981
40. Kendall G., and Peebles D. Acute fetal hypoxia: the modulating effect of infection. Early Hum. Dev. 81 (2005) 27-34
41. Kischkel F.C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P.H., and Peter M.E. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14 (1995) 5579-5588
42. Kobayashi T., Walsh M.C., and Choi Y. The role of TRAF6 in signal transduction and the immune response. Microbes Infect. 6 (2004) 1333-1338
43. Kopp E.B., and Medzhitov R. The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 11 (1999) 13-18
44. Kremlev S.G., and Palmer C. Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures. J. Neuroimmunol. 162 (2005) 71-80
45. Lee J.E., Yenari M.A., Sun G.H., Xu L., Emond M.R., Cheng D., Steinberg G.K., and Giffard R.G. Differential neuroprotection from human heat shock protein 70 overexpression in in vitro and in vivo models of ischemia and ischemia-like conditions. Exp. Neurol. 170 (2001) 129-139
46. Lehtimaki K.A., Peltola J., Koskikallio E., Keranen T., and Honkaniemi J. Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures. Brain Res. Mol. Brain Res. 110 (2003) 253-260
47. Letai A. Pharmacological manipulation of Bcl-2 family members to control cell death. J. Clin. Invest. 115 (2005) 2648-2655
48. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) method. Methods 25 (2001) 402-408
49. Lu W., Maheshwari A., Misiuta I., Fox S.E., Chen N., Zigova T., Christensen R.D., and Calhoun D.A. Neutrophil-specific chemokines are produced by astrocytic cells but not by neuronal cells. Brain Res. Dev. Brain Res. 155 (2005) 127-134
50. Martin-Villalba A., Herr I., Jeremias I., Hahne M., Brandt R., Vogel J., Schenkel J., Herdegen T., and Debatin K.M. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J. Neurosci. 19 (1999) 3809-3817
51. Martin-Villalba A., Hahne M., Kleber S., Vogel J., Falk W., Schenkel J., and Krammer P.H. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ. 8 (2001) 679-686
52. Maslinska D., Laure-Kamionowska M., and Maslinski S. Toll-like receptors in rat brains injured by hypoxic-ischaemia or exposed to staphylococcal alpha-toxin. Folia Neuropathol. 42 (2004) 125-132
53. Matsumori Y., Hong S.M., Aoyama K., Fan Y., Kayama T., Sheldon R.A., Vexler Z.S., Ferriero D.M., Weinstein P.R., and Liu J. Hsp70 overexpression sequesters AIF and reduces neonatal hypoxic/ischemic brain injury. J. Cereb. Blood Flow Metab. 25 (2005) 899-910
54. Matsushita K., Matsuyama T., Kitagawa K., Matsumoto M., Yanagihara T., and Sugita M. Alterations of Bcl-2 family proteins precede cytoskeletal proteolysis in the penumbra, but not in infarct centres following focal cerebral ischemia in mice. Neuroscience 83 (1998) 439-448
55. Mehmet H. Stroke treatment enters the Fas lane. Cell Death Differ. 8 (2001) 659-661
56. Munir M., Lu L., and McGonigle P. Excitotoxic cell death and delayed rescue in human neurons derived from NT2 cells. J. Neurosci. 15 (1995) 7847-7860
57. Nagata S., and Golstein P. The Fas death factor. Science 267 (1995) 1449-1456
58. Nawashiro H., Martin D., and Hallenbeck J.M. Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain Res. 778 (1997) 265-271
59. Neelands T.R., King A.P., and Macdonald R.L. Functional expression of L-, N-, P/Q-, and R-type calcium channels in the human NT2-N cell line. J. Neurophysiol. 84 (2000) 2933-2944
60. Northington F.J., Ferriero D.M., Flock D.L., and Martin L.J. Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J. Neurosci. 21 (2001) 1931-1938
61. Penrice J., Lorek A., Cady E.B., Amess P.N., Wylezinska M., Cooper C.E., D'Souza P., Brown G.C., Kirkbride V., Edwards A.D., Wyatt J.S., and Reynolds E.O. Proton magnetic resonance spectroscopy of the brain during acute hypoxia-ischemia and delayed cerebral energy failure in the newborn piglet. Pediatr. Res. 41 (1997) 795-802
62. Rajdev S., Hara K., Kokubo Y., Mestril R., Dillmann W., Weinstein P.R., and Sharp F.R. Mice overexpressing rat heat shock protein 70 are protected against cerebral infarction. Ann. Neurol. 47 (2000) 782-791
63. Ran R., Lu A., Zhang L., Tang Y., Zhu H., Xu H., Feng Y., Han C., Zhou G., Rigby A.C., and Sharp F.R. Hsp70 promotes TNF-mediated apoptosis by binding IKK gamma and impairing NF-kappa B survival signaling. Genes Dev. 18 (2004) 1466-1481
64. Rootwelt T., Dunn M., Yudkoff M., Itoh T., Almaas R., and Pleasure D. Hypoxic cell death in human NT2-N neurons: involvement of NMDA and non-NMDA glutamate receptors. J. Neurochem. 71 (1998) 1544-1553
65. Rosenbaum D.M., Gupta G., D'Amore J., Singh M., Weidenheim K., Zhang H., and Kessler J.A. Fas (CD95/APO-1) plays a role in the pathophysiology of focal cerebral ischemia. J. Neurosci. Res. 61 (2000) 686-692
66. Saleh A., Srinivasula S.M., Balkir L., Robbins P.D., and Alnemri E.S. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat. Cell Biol. 2 (2000) 476-483
67. Semenza G.L. HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol. 13 (2001) 167-171
68. Siemkowicz E., and Hansen A.J. Brain extracellular ion composition and EEG activity following 10 minutes ischemia in normo- and hyperglycemic rats. Stroke 12 (1981) 236-240
69. Sodja C., Fang H., Dasgupta T., Ribecco M., Walker P.R., and Sikorska M. Identification of functional dopamine receptors in human teratocarcinoma NT2 cells. Brain Res. Mol. Brain Res. 99 (2002) 83-91
70. Srinivasan D., Yen J.H., Joseph D.J., and Friedman W. Cell type-specific interleukin-1beta signaling in the CNS. J. Neurosci. 24 (2004) 6482-6488
71. Stumm R.K., Rummel J., Junker V., Culmsee C., Pfeiffer M., Krieglstein J., Hollt V., and Schulz S. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J. Neurosci. 22 (2002) 5865-5878
72. Tamatani M., Ogawa S., and Tohyama M. Roles of Bcl-2 and caspases in hypoxia-induced neuronal cell death: a possible neuroprotective mechanism of peptide growth factors. Brain Res. Mol. Brain Res. 58 (1998) 27-39
73. Thier M., Marz P., Otten U., Weis J., and Rose-John S. Interleukin-6 (IL-6) and its soluble receptor support survival of sensory neurons. J. Neurosci. Res. 55 (1999) 411-422
74. Tsuchiya D., Hong S., Matsumori Y., Kayama T., Swanson R.A., Dillman W.H., Liu J., Panter S.S., and Weinstein P.R. Overexpression of rat heat shock protein 70 reduces neuronal injury after transient focal ischemia, transient global ischemia, or kainic acid-induced seizures. Neurosurgery 53 (2003) 1179-1187
75. Valerio A., Ferrario M., Martinez F.O., Locati M., Ghisi V., Bresciani L.G., Mantovani A., and Spano P. Gene expression profile activated by the chemokine CCL5/RANTES in human neuronal cells. J. Neurosci. Res. 78 (2004) 371-382
76. Willam C., Warnecke C., Schefold J.C., Kugler J., Koehne P., Frei U., Wiesener M., and Eckardt K.U. Inconsistent effects of acidosis on HIF-alpha protein and its target genes. Pflugers Arch. 451 (2006) 534-543
77. Yang E., and Korsmeyer S.J. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88 (1996) 386-401